| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_72824ca852edca43846b72453b43a60d |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-763 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-763
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-76 |
| filingDate |
2013-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2fbc5a19f924b95b983ae4a13b78efaf |
| publicationDate |
2014-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2014053852-A1 |
| titleOfInvention |
Treatment of cancer |
| abstract |
The present disclosure relates to the use of an oncolytic virus and a JAK inhibitor in the treatment of cancer. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107073120-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108530337-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016201265-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020210711-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021168200-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11401511-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107073120-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11738058-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018187163-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10577591-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019226514-A2 |
| priorityDate |
2012-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |